Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 13 min ago
Peer-reviewedCC BYJTCVS open

Coronary sinus lactate at reperfusion: A predictor of atrial fibrillation after coronary artery bypass grafting.

  1. 1Division of Cardiac Surgery, Mass General Brigham, Harvard Medical School, Boston, Mass.

Abstract

Objective

Postoperative atrial fibrillation (POAF) is the most common complication after coronary artery bypass grafting (CABG). This study explored the association of coronary sinus (CS) lactate levels with POAF after CABG.Methods

This was a single-center prospective cohort study of patients without a history of atrial fibrillation undergoing isolated CABG (December 2024 to February 2026). CS lactate was sampled before initiation of cardiopulmonary bypass (pre-CPB), before cross-clamp removal (pre-XC), and after cross-clamp removal (post-XC). POAF was defined as electrocardiogram-documented atrial fibrillation treated with amiodarone during the index hospitalization. Restricted cubic splines were used to define a binary cutoff of post-XC CS lactate at >3 mmol/L. Multivariable logistic regression was performed to assess the association between CS lactate elevation and POAF.Results

Of the 94 patients included, POAF occurred in 24 patients (26%). Patients with POAF were older and more commonly male but had similar median CPB time and XC duration. Patients with a post-XC lactate >3 mmol/L (n = 13/94, 14%) had significantly greater rates of POAF compared with those without lactate elevation (62% vs 20%, P = .001). After risk adjustment, post-XC lactate >3 mmol/L was associated with a 11.7-fold increase in odds of POAF (P = .010). Increasing age was also linked to greater likelihood of POAF. There was no significant association of POAF with CPB time, XC duration, pre-CPB CS lactate, or pre-XC CS lactate.Conclusions

Elevated CS lactate after cardiac reperfusion was associated with increased likelihood of POAF. Our findings suggest that CS lactate may be used to guide POAF prophylaxis.

Related

  1. Association of the triglyceride-glucose index and triglyceride-glucose-body mass index with postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study
    Zhiyuan Song, Jiawei Wu, Ze Bu +6
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Standardized 4-step surgical approach to address atrial fibrillation during coronary artery bypass grafting in a patient with severely reduced left ventricular function: a case report
    Johannes Gökler, Philipp Szalkiewicz, Ilinca Damian +3
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref
  3. Reduced apelin expression and atrial fibrosis in postoperative atrial fibrillation following coronary artery bypass grafting
    Yijun Xu, Zhiqiang Chen, Peng Liu +3
    Biomolecules & BiomedicinePeer-reviewedCC BYFull textPharmacology & toxicologyDOAJ
  4. Association between rhythm control strategy and clinical outcomes in postoperative atrial fibrillation after coronary artery bypass grafting: a retrospective cohort study
    Xianglin Long, Weiwu Xiong, Yeshen Zhang +3
    BMC Cardiovascular DisordersPeer-reviewedCC BYFull textCardiovascular medicineDOAJ
  5. Pericardial fluid cardiac troponin I predicts postoperative atrial fibrillation after coronary artery bypass grafting.
    Yue Shu, Chaoyue Gao, Xiaoshuang Ren +6
    JTCVS openPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMCPMC
BibTeX
@article{verma2026coronary,
  title = {{Coronary sinus lactate at reperfusion: A predictor of atrial fibrillation after coronary artery bypass grafting.}},
  author = {Arjun Verma and Borami Shin and Sameer Hirji and Michael Gilfeather and Tommaso Hinna Danesi and Ashraf A Sabe and Thoralf M Sundt and Sary F Aranki},
  journal = {JTCVS open},
  year = {2026},
  month = jul,
  doi = {10.1016/j.xjon.2026.101971},
  url = {https://europepmc.org/article/MED/42948100},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Coronary sinus lactate at reperfusion: A predictor of atrial fibrillation after coronary artery bypass grafting.
AU  - Arjun Verma
AU  - Borami Shin
AU  - Sameer Hirji
AU  - Michael Gilfeather
AU  - Tommaso Hinna Danesi
AU  - Ashraf A Sabe
AU  - Thoralf M Sundt
AU  - Sary F Aranki
PY  - 2026
DA  - 2026/07/24
JO  - JTCVS open
DO  - 10.1016/j.xjon.2026.101971
UR  - https://europepmc.org/article/MED/42948100
AB  - Objective  Postoperative atrial fibrillation (POAF) is the most common complication after coronary artery bypass grafting (CABG). This study explored the association of coronary sinus (CS) lactate levels with POAF after CABG.Methods  This was a single-center prospective cohort study of patients without a history of atrial fibrillation undergoing isolated CABG (December 2024 to February 2026). CS lactate was sampled before initiation of cardiopulmonary bypass (pre-CPB), before cross-clamp removal (pre-XC), and after cross-clamp removal (post-XC). POAF was defined as electrocardiogram-documented atrial fibrillation treated with amiodarone during the index hospitalization. Restricted cubic splines were used to define a binary cutoff of post-XC CS lactate at >3 mmol/L. Multivariable logistic regression was performed to assess the association between CS lactate elevation and POAF.Results  Of the 94 patients included, POAF occurred in 24 patients (26%). Patients with POAF were older and more commonly male but had similar median CPB time and XC duration. Patients with a post-XC lactate >3 mmol/L (n = 13/94, 14%) had significantly greater rates of POAF compared with those without lactate elevation (62% vs 20%, P = .001). After risk adjustment, post-XC lactate >3 mmol/L was associated with a 11.7-fold increase in odds of POAF (P = .010). Increasing age was also linked to greater likelihood of POAF. There was no significant association of POAF with CPB time, XC duration, pre-CPB CS lactate, or pre-XC CS lactate.Conclusions  Elevated CS lactate after cardiac reperfusion was associated with increased likelihood of POAF. Our findings suggest that CS lactate may be used to guide POAF prophylaxis.
SN  - 2666-2736
ER  -